<DOC>
	<DOCNO>NCT00766090</DOCNO>
	<brief_summary>The purpose study compare twice daily GW685698 asthma</brief_summary>
	<brief_title>Safety Efficacy GW685698X Inhaled Corticosteroid Once Daily Twice Daily Treatment Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Key Clinical diagnosis Asthma Reversibility ≥ 12 % ≥200mls reversibility FEV1 within approximately 30minutes follow 2 4 puff albuterol FEV1 4085 % predict Currently short act beta2 agonist therapy Key History life threaten asthma Respiratory Infection oropharyngeal candidiasis Asthma exacerbation Uncontrolled disease clinical abnormality Allergies Taking another Investigational medication prohibit medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>